Block, clear, and boost: a novel therapeutic framework for targeting intercellular mitochondrial transfer in Cancer...

Area of Science:

• Mitochondrial biology and cancer immunology
• Tumor microenvironment and intercellular communication

Background:

• Intercellular mitochondrial transfer (IMT) is a key process in the tumor microenvironment (TME).
• Mitochondria can be exchanged via tunneling nanotubes (TNTs), extracellular vesicles (EVs), and other routes.
• The quality of transferred mitochondria dictates their impact on recipient cells and immune function.

Purpose of the Study:

• To review the role of IMT in cancer and its impact on the tumor-immune interface.
• To propose a novel "Block, Clear, and Boost" framework for IMT modulation in cancer immunotherapy.
• To identify potential biomarkers and future research directions for IMT-targeted therapies.

Main Methods:

• Literature review and synthesis of existing research on IMT in cancer.
• Analysis of mitochondrial quality control mechanisms (e.g., PINK1-Parkin, USP30).
• Discussion of IMT's role in both adaptive and innate immunity within the TME.

Main Results:

• IMT influences tumor cell bioenergetics, signaling, and drug resistance.
• Cancer cells can acquire mitochondria from non-malignant cells, enhancing their metastatic potential.
• Mitochondrial transfer can either support or impair immune cell function depending on mitochondrial quality.

Conclusions:

• The "Block, Clear, and Boost" framework offers a hypothesis-generating approach for cancer immunotherapy.
• Clinical validation of this framework requires route-specific and cell-type-specific studies.
• Biomarkers and further research are crucial for translating IMT modulation into effective cancer treatments alongside existing immunotherapies like ICIs and ACTs.